Abstract: Disclosed are an image-processing circuit capable of improving the ability to express a high-resolution image and a display device having the same and a method of driving a display device. The image-processing circuit determines whether input image data represents one or more of a forward diagonal line edge, a backward diagonal line edge, and a horizontal line edge, and then determines arrangement of a center unit pixel, and thereafter renders data of the center unit pixel into data of a peripheral unit pixel based on edge information and the arrangement of the center unit pixel.

Abstract: A user terminal apparatus and an iris recognition method thereof are provided. The user terminal apparatus includes an imaging unit configured to generate an image of a user, a display configured to display the generated image, and a controller configured to detect a user eye from the generated image, control the display to display a guide image in a position of the generated image in which the detected user eye is located, and perform iris recognition in response to a difference between a size of an iris included in the detected user eye and a size of the guide image being within a preset range.

Abstract: A terminal device is provided. The terminal device includes a communication interface unit configured to receive image data of an application installed in another terminal device that is streamed from the another terminal device, a display unit configured to display the image data, a control unit configured to receive an installation file associated with the application through the communication interface unit while the image data is being displayed, and to execute the received installation file when authentication of the installation file is completed, and a storage unit configured to allow the application to be installed therein according to execution of the installation file.

Abstract: A user terminal apparatus and an iris recognition method thereof are provided. The user terminal apparatus includes an imaging unit configured to generate an image of a user, a display configured to display the generated image, and a controller configured to detect a user eye from the generated image, control the display to display a guide image in a position of the generated image in which the detected user eye is located, and perform iris recognition in response to a difference between a size of an iris included in the detected user eye and a size of the guide image being within a preset range.

Abstract: The present invention relates to an apparatus and a method for executing a desired application on any screen of a mobile device by a simple operation without switching a screen. The apparatus for executing an application for a mobile device according to one embodiment of the present invention comprises: a text input unit; an application recognition unit for recognizing an application to be executed; a message recognition unit for recognizing an operation message to be performed in the application to be executed on the basis of the text which is inputted through the text input unit; a transmission instruction sensing unit for sensing an operation message transmission instruction of a user; a message transfer unit for transferring the operation message to the application when the transmission instruction sensing unit senses the operation message transmission instruction; and an application execution unit for executing the operation message transferred by the message transfer unit.

Abstract: Provided are a pyranochromenyl phenol derivative, a pharmaceutically acceptable salt thereof, or a solvate thereof. Also provided is a pharmaceutical composition for preventing or treating metabolic syndrome or inflammatory disease comprising same. The present invention is efficacious in preventing or treating metabolic syndrome or inflammatory disease and is chemically stable.

Abstract: A touch screen panel may include a liquid crystal, a first transparent electrode and a second transparent electrode provided at both sides of the liquid crystal, and a controller configured to transfer image data to the first transparent electrode and the second transparent electrode in a first mode and sense a touch of a user on at least one of the first transparent electrode and the second transparent electrode in a second mode.

Abstract: A method of manufacturing an sensor array includes providing a glass substrate; forming a bottom electrode layer over the glass substrate; forming a sensor material layer over the bottom electrode layer; forming a top electrode layer over the sensor material layer; patterning the top electrode layer, the sensor material layer, and the bottom electrode layer using a first photoresist layer to form a plurality of pixels; detecting a defect in the plurality of pixels; and patterning the plurality of pixels using a second photoresist layer. The first photoresist layer includes a plurality of first pixel patterns and the second photoresist layer comprises a plurality of second pixel patterns, and wherein at least one of the second pixel patterns has an area greater than that of a corresponding first pixel pattern.

Abstract: Disclosed are an image-processing circuit capable of improving the ability to express a high-resolution image and a display device having the same and a method of driving a display device. The image-processing circuit determines whether input image data represents one or more of a forward diagonal line edge, a backward diagonal line edge, and a horizontal line edge, and then determines arrangement of a center unit pixel, and thereafter renders data of the center unit pixel into data of a peripheral unit pixel based on edge information and the arrangement of the center unit pixel.

Abstract: Provided are a pyranochromenyl phenol derivative, a pharmaceutically acceptable salt thereof, or a solvate thereof. Also provided is a pharmaceutical composition for preventing or treating metabolic syndrome or inflammatory disease comprising same. The present invention is efficacious in preventing or treating metabolic syndrome or inflammatory disease and is chemically stable.

Abstract: The present invention relates to a method, an apparatus, and a computer-readable recording medium for improving at least one semantic unit set by using a phonetic sound. The method for improving a set including at least one semantic unit, in which the set including at least one semantic unit is a captured semantic unit set, includes: receiving an improvement phonetic sound according to utterance of a user; specifying an improvement semantic unit set on the basis of the improvement phonetic sound; specifying a semantic unit set as a target to be actually improved within the captured semantic unit set, as a matched semantic unit set, on the basis of correlation thereof with the improvement semantic unit set; and replacing the matched semantic unit set within the captured semantic unit set with the improvement semantic unit set.

Abstract: Disclosed herein are a secondary battery transfer apparatus for transferring a secondary battery in a secondary battery manufacturing process and a method for detecting a loading defect of a secondary battery in a carrier receiving the secondary battery. The secondary battery transfer apparatus includes a carrier having a receipt space to receive a secondary battery, a transfer unit transferring the carrier, a loading detection sensor sensing the secondary battery when the secondary battery inserted into the carrier reaches a designated height, and a controller receiving a result of sensing of the loading detection sensor and controlling operation of the transfer unit. The secondary battery transfer apparatus and the detection method detect whether or not a case of the secondary battery is damaged due to friction with the carrier and thus recognize a product defect in advance.

Abstract: A method of wirelessly connecting a first device to a target device is provided. The method includes searching for at least one device located in an orientation region of the first device, when a first input signal is received, determining the target device based on a direction that the first device is oriented, performing a wireless connection with the target device, and determining whether to maintain the wireless connection with the target device, when a second input signal is received.

Abstract: A service providing method including transmitting user ID information to a service terminal, receiving first service information from a server, and controlling a user terminal to provide a service using received first service information.

Abstract: A user terminal apparatus and an iris recognition method thereof are provided. The user terminal apparatus includes an imaging unit configured to generate an image of a user, a display configured to display the generated image, and a controller configured to detect a user eye from the generated image, control the display to display a guide image in a position of the generated image in which the detected user eye is located, and perform iris recognition in response to a difference between a size of an iris included in the detected user eye and a size of the guide image being within a preset range.

Abstract: A terminal device is provided. The terminal device includes a communication interface unit configured to receive image data of an application installed in another terminal device that is streamed from the another terminal device, a display unit configured to display the image data, a control unit configured to receive an installation file associated with the application through the communication interface unit while the image data is being displayed, and to execute the received installation file when authentication of the installation file is completed, and a storage unit configured to allow the application to be installed therein according to execution of the installation file.

Abstract: Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof. wherein R1 through R8 and n are as defined in this disclosure.

Abstract: The present invention relates to, in the toner including toner particles having a biding agent resin, colorings and a release agent, an electrostatic image developing toner, its composition, and a preparation method thereof. The electrostatic image developing toner is prepared by the method comprising: (1) preparing an inorganic dispersion medium; (2) dispersing/dissolving a polymerizable monomer mixture; (3) micronizing the liquid obtained in step (2) in the liquid obtained in step (1) with high shear force in order to create droplets; (4) performing radical polymerization of the micronized droplets obtained in step (3); (5) aggregating particles obtained in step (4); (6) fusing the aggregate obtained in step (5); (7) cleaning and drying the toner obtained by step (6); and (8) adding additives to impart electrification and fluidity to a toner obtained by step (7).

Abstract: Provided is a method capable of effectively treating various diseases associated with energy excess, such as obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, via elevation of an NAD(P)+/NAD(P)H ratio by increasing an NAD(P)+ concentration in vivo or in vitro through use of NAD(P)H as a substrate or coenzyme by oxidoreductase such as NAD(P)H:quinone oxidoreductase (NQO1), a method of screening a drug for the same and a therapeutic drug.

Abstract: Provided is a pharmaceutical composition for the treatment and prevention of obesity, diabetes, metabolic syndromes, degenerative diseases and mitochondrial dysfunction-related diseases, comprising: a therapeutically effective amount of a compound represented by Formula I below, or a pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, and a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof. wherein R1 through R8 and n are as defined in this disclosure.